Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Liposomal Amphotericin B Gel for Cutaneous Leishmaniasis
NCT02656797Phase 2Completed
- Sponsor
- Soroka University Medical Center
- Start
- Jan 2018
- Primary completion
- Jun 2021
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amphotericin B liposomal in cutaneous leishmaniasis (CL), sponsored by Soroka University Medical Center. Started Jan 2018; status: completed.
02
Drugs
amphotericin B liposomal
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT02656797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02656797.